BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Issa H, Eid AH, Berry B, Takhviji V, Khosravi A, Mantash S, Nehme R, Hallal R, Karaki H, Dhayni K, Faour WH, Kobeissy F, Nehme A, Zibara K. Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19. Front Med (Lausanne) 2021;8:620990. [PMID: 33816521 DOI: 10.3389/fmed.2021.620990] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Devaux CA, Camoin-jau L. An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1042200] [Reference Citation Analysis]
2 Razi O, Teixeira AM, Tartibian B, Zamani N, Knechtle B. Respiratory issues in patients with multiple sclerosis as a risk factor during SARS-CoV-2 infection: a potential role for exercise. Mol Cell Biochem 2022. [DOI: 10.1007/s11010-022-04610-1] [Reference Citation Analysis]
3 Karimi F, Maleki M, Nematbakhsh M, Sun M. View of the Renin-Angiotensin System in Acute Kidney Injury Induced by Renal Ischemia-Reperfusion Injury. Journal of the Renin-Angiotensin-Aldosterone System 2022;2022:1-10. [DOI: 10.1155/2022/9800838] [Reference Citation Analysis]
4 Presti EL, Nuzzo D, Al Mahmeed W, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh SY, Janez A, Kalra S, Kapoor N, Kempler P, Lessan N, Lotufo P, Papanas N, Rizvi AA, Sahebkar A, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M; CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO). Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health. Biochim Biophys Acta Mol Basis Dis 2022;:166559. [PMID: 36174875 DOI: 10.1016/j.bbadis.2022.166559] [Reference Citation Analysis]
5 Lin CY, Su SB, Chen KT. An overview of gastrointestinal diseases in patients with COVID-19: A narrative review. Medicine (Baltimore) 2022;101:e30297. [PMID: 36086768 DOI: 10.1097/MD.0000000000030297] [Reference Citation Analysis]
6 Chi LA, Asgharpour S, Correa-Basurto J, Bandala CR, Martínez-Archundia M. Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide by molecular dynamics simulations. J Comput Aided Mol Des 2022. [PMID: 35934747 DOI: 10.1007/s10822-022-00470-5] [Reference Citation Analysis]
7 Sultan RH, Elesawy BH, Ali TM, Abdallah M, Assal HH, Ahmed AE, Ahmed OM. Correlations between Kidney and Heart Function Bioindicators and the Expressions of Toll-Like, ACE2, and NRP-1 Receptors in COVID-19. Vaccines 2022;10:1106. [DOI: 10.3390/vaccines10071106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Barekat M, Shahrbaf MA, Rahi K, Vosough M. Hypertension in COVID-19, A Risk Factor for Infection or A Late Consequence? Cell J 2022;24:424-6. [PMID: 36043411 DOI: 10.22074/cellj.2022.8487] [Reference Citation Analysis]
9 Fé LXSGM, Cipolatti EP, Pinto MCC, Branco S, Nogueira FCS, Ortiz GMD, Pinheiro AS, Manoel EA. Enzymes in the time of COVID-19: An overview about the effects in the human body, enzyme market, and perspectives for new drugs. Med Res Rev 2022. [PMID: 35762498 DOI: 10.1002/med.21919] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Chi LA, Asgharpour S, Correa-basurto J, Bandala CR, Martínez-archundia M. Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide.. [DOI: 10.1101/2022.05.23.493150] [Reference Citation Analysis]
11 Sultan RH, Abdallah M, Ali TM, Assal HH, Ahmed AE, Elesawy BH, Ahmed OM. Correlations between kidney and heart function bioindicators and the expressions of Toll-Like, ACE2, and NRP-1 receptors in COVID-19.. [DOI: 10.1101/2022.04.08.22273322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Soltani Hekmat A, Javanmardi K. Alamandine: Potential Protective Effects in SARS-CoV-2 Patients. J Renin Angiotensin Aldosterone Syst 2021;2021:6824259. [PMID: 34853605 DOI: 10.1155/2021/6824259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Cai W, Marouf N, Said KN, Tamimi F. Nature of the Interplay Between Periodontal Diseases and COVID-19. Front Dent Med 2021;2:735126. [DOI: 10.3389/fdmed.2021.735126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Pucci F, Annoni F, Dos Santos RAS, Taccone FS, Rooman M. Quantifying Renin-Angiotensin-System Alterations in COVID-19. Cells 2021;10:2755. [PMID: 34685735 DOI: 10.3390/cells10102755] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
15 Dąbrowska E, Galińska-Skok B, Waszkiewicz N. Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19. Life (Basel) 2021;11:1056. [PMID: 34685427 DOI: 10.3390/life11101056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
16 Nazerian Y, Vakili K, Ebrahimi A, Niknejad H. Developing Cytokine Storm-Sensitive Therapeutic Strategy in COVID-19 Using 8P9R Chimeric Peptide and Soluble ACE2. Front Cell Dev Biol 2021;9:717587. [PMID: 34540833 DOI: 10.3389/fcell.2021.717587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]